NOUV Stock Is Winner Of Tuesday’s Penny Stock PR Bingo

Hot Penny StocksMany trading session begin where hot penny stocks have a huge day based on an $85 press release of a planned merger or a letter of intent signing. With this in mind, we at AimHighProfits thought it would be a good idea to cover the Companies we track that sent out press releases prior to the open of Tuesday, July 10, trading session to see how ...

Continue Reading →
0

Don’t Leave That Screen: ADXS and RGIN Stock are Surging

Just 15 minutes into the trading session and Advaxis Inc. (OTC: ADXS) stock price is already up 16.67% at 0.105 on volume of 1,490,507 shares. Regenicin, Inc. (OTC: RGIN) isn’t doing so bad either up 48.15% at 0.40 on volume of 1,754,632 shares. Traders in these two hot biotech penny stocks must be planning to dine-in this ...

Continue Reading →
0

Advaxis (ADXS): Battle Against Cervical Cancer Progressing

Trading at under a dime, Advaxis Inc., (OTC: ADXS) stock should be on the list of penny stocks to watch, as we mentioned on Monday. ADXS, a leader in developing the next generation of immunotherapies for cancer and infectious diseases and winner of the 2012 Novartis Best Therapeutic Vaccine (approved ...

Continue Reading →
0

Update Alert: Zacks Initiates Coverage on Advaxis ADXS

Monday’s penny stock alert, Advaxis Inc. (OTC: ADXS) traded as high as 0.106, 8.16% from Friday’s close, on volume of roughly 2.47 million shares. More importantly is that ADXS was given an “outperform” rating by Zacks Small-Cap Research citing that the stock of the biotech company was “undervalued.” Highlights include that Zacks has given a price target of $0.20 per share ...

Continue Reading →
0

Top 10 Penny Stocks: Get Advaxis Inc. (ADXS) on the List

Monday morning trading has started off with an unfamiliar name on the list of the top 10 penny stocks; Advaxis Inc. (OTC: ADXS).  ADXS is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. In April 2012, the Company’s ADXS-HPV was chosen as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence ...

Continue Reading →
0